5-MeO-DMT vs Ayahuasca
A side-by-side research comparison of 5-MeO-DMT and Ayahuasca across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | 5-MeO-DMT | Ayahuasca |
|---|---|---|
| Full name | 5-Methoxy-N,N-dimethyltryptamine | Ayahuasca (DMT + MAO inhibitor brew) |
| Category | Psychedelics | Psychedelics |
| Status | Schedule I (research compound) | Traditional/ceremonial; research compound |
| Mechanism | Strongly activates serotonin 5-HT1A and 5-HT2A receptors, producing rapid and intense changes in consciousness. | The MAO-inhibiting vine (harmine and related compounds) stops the body from breaking down DMT, allowing an oral psychedelic experience that activates serotonin 5-HT2A receptors. |
| Molecular weight | 218.30 g/mol | Mixture (no single value) |
| Half-life | Short (minutes) | Several hours (extended by MAO inhibition) |
| Bioavailability | Inhaled/injected | Oral |
| Typical dose | Low milligram range in clinical studies | Brew-based, varies by preparation |
| Frequency | One to a few supervised sessions | Ceremonial or occasional study sessions |
| Route | Inhalation or injection in research settings | Oral brew |
5-MeO-DMT reported benefits
- Studied for treatment-resistant depression
- Short duration suits clinical use
- Explored for anxiety
- Rapid onset of effects
Ayahuasca reported benefits
- Studied for treatment-resistant depression
- Explored for grief and trauma
- Long history of ceremonial use
- May produce lasting shifts in outlook
Related comparisons
Research and educational reference only. Not medical advice.